Crossmark

Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study

Crossref DOI link: https://doi.org/10.1186/s12885-018-4891-7

Published Online: 2018-10-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Min Kyoung

Yee, Jeong

Cho, Yoon Sook

Jang, Hong Won

Han, Ji Min

Gwak, Hye Sun https://orcid.org/0000-0003-0278-2563
License Information

Text and Data Mining valid from 2018-10-16
More Information

Article History

Received: 21 January 2018

Accepted: 3 October 2018

First Online: 16 October 2018

Ethics approval and consent to participate

: This study was approved by the Seoul National University Hospital Institutional Review Board (IRB # H-1710-087-894). The informed consent of participants was waived by the Seoul National University Hospital Institutional Review Board.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.